112 related articles for article (PubMed ID: 23180025)
21. Irreversible electroporation for the treatment of rabbit VX2 breast cancer.
Zhang W; Chai W; Zeng J; Chen J; Bi L; Niu L
Biomed Microdevices; 2017 Jun; 19(2):29. PubMed ID: 28417251
[TBL] [Abstract][Full Text] [Related]
22. Efficacy and mechanism of steep pulse irreversible electroporation technology on xenograft model of nude mice: a preclinical study.
Song Z; Xu X; Liu M; Liu J; Chen J; Li C; Yao C; Zhou Q
World J Surg Oncol; 2018 Apr; 16(1):84. PubMed ID: 29695251
[TBL] [Abstract][Full Text] [Related]
23. Treatment planning of electroporation-based medical interventions: electrochemotherapy, gene electrotransfer and irreversible electroporation.
Zupanic A; Kos B; Miklavcic D
Phys Med Biol; 2012 Sep; 57(17):5425-40. PubMed ID: 22864181
[TBL] [Abstract][Full Text] [Related]
24. Parametric study of irreversible electroporation with different needle electrodes: electrical and thermal analysis.
Nickfarjam A; Firoozabadi SM
Int J Hyperthermia; 2014 Aug; 30(5):335-47. PubMed ID: 25144823
[TBL] [Abstract][Full Text] [Related]
25. Irreversible electroporation in the eradication of rabbit VX2 cervical tumors.
Chai W; Xu Y; Zhang W; Wei Z; Li J; Shi J; Luo X; Zeng J; Cui M; Niu L
Biomed Microdevices; 2017 Oct; 19(4):90. PubMed ID: 28993931
[TBL] [Abstract][Full Text] [Related]
26. Irreversible electroporation: just another form of thermal therapy?
van Gemert MJ; Wagstaff PG; de Bruin DM; van Leeuwen TG; van der Wal AC; Heger M; van der Geld CW
Prostate; 2015 Feb; 75(3):332-5. PubMed ID: 25327875
[TBL] [Abstract][Full Text] [Related]
27. Suppression of LNCaP prostate cancer xenograft tumors by a prostate-specific protein tyrosine phosphatase, prostatic acid phosphatase.
Igawa T; Lin FF; Rao P; Lin MF
Prostate; 2003 Jun; 55(4):247-58. PubMed ID: 12712404
[TBL] [Abstract][Full Text] [Related]
28. Controllable Moderate Heating Enhances the Therapeutic Efficacy of Irreversible Electroporation for Pancreatic Cancer.
Edelblute CM; Hornef J; Burcus NI; Norman T; Beebe SJ; Schoenbach K; Heller R; Jiang C; Guo S
Sci Rep; 2017 Sep; 7(1):11767. PubMed ID: 28924200
[TBL] [Abstract][Full Text] [Related]
29. Pre-treatment inflammation induced by TNF-alpha augments cryosurgical injury on human prostate cancer.
Chao BH; He X; Bischof JC
Cryobiology; 2004 Aug; 49(1):10-27. PubMed ID: 15265713
[TBL] [Abstract][Full Text] [Related]
30. Thermal therapy of prostate tumor tissue in the dorsal skin flap chamber.
Bhowmick S; Hoffmann NE; Bischof JC
Microvasc Res; 2002 Jul; 64(1):170-3. PubMed ID: 12074643
[No Abstract] [Full Text] [Related]
31. Treatment of breast cancer through the application of irreversible electroporation using a novel minimally invasive single needle electrode.
Neal RE; Singh R; Hatcher HC; Kock ND; Torti SV; Davalos RV
Breast Cancer Res Treat; 2010 Aug; 123(1):295-301. PubMed ID: 20191380
[TBL] [Abstract][Full Text] [Related]
32. Stromal cells promote angiogenesis and growth of human prostate tumors in a differential reactive stroma (DRS) xenograft model.
Tuxhorn JA; McAlhany SJ; Dang TD; Ayala GE; Rowley DR
Cancer Res; 2002 Jun; 62(11):3298-307. PubMed ID: 12036948
[TBL] [Abstract][Full Text] [Related]
33. Evaluation of thermal therapy in a prostate cancer model using a wet electrode radiofrequency probe.
Bhowmick S; Swanlund DJ; Coad JE; Lulloff L; Hoey MF; Bischof JC
J Endourol; 2001 Aug; 15(6):629-40. PubMed ID: 11552790
[TBL] [Abstract][Full Text] [Related]
34. Why we should not routinely apply irreversible electroporation as an alternative curative treatment modality for localized prostate cancer at this stage.
Wendler JJ; Ganzer R; Hadaschik B; Blana A; Henkel T; Köhrmann KU; Machtens S; Roosen A; Salomon G; Sentker L; Witzsch U; Schlemmer HP; Baumunk D; Köllermann J; Schostak M; Liehr UB
World J Urol; 2017 Jan; 35(1):11-20. PubMed ID: 27147512
[TBL] [Abstract][Full Text] [Related]
35. Characterization of Conductivity Changes During High-Frequency Irreversible Electroporation for Treatment Planning.
Zhao Y; Bhonsle S; Dong S; Lv Y; Liu H; Safaai-Jazi A; Davalos RV; Yao C
IEEE Trans Biomed Eng; 2018 Aug; 65(8):1810-1819. PubMed ID: 29989932
[TBL] [Abstract][Full Text] [Related]
36. Use of conductive gels for electric field homogenization increases the antitumor efficacy of electroporation therapies.
Ivorra A; Al-Sakere B; Rubinsky B; Mir LM
Phys Med Biol; 2008 Nov; 53(22):6605-18. PubMed ID: 18978447
[TBL] [Abstract][Full Text] [Related]
37. [Irreversible electroporation. Current value for focal treatment of prostate cancer].
Wendler JJ; Ganzer R; Hadaschik B; Blana A; Henkel T; Köhrmann KU; Machtens S; Roosen A; Salomon G; Sentker L; Witzsch U; Schlemmer HP; Baumunk D; Köllermann J; Schostak M; Liehr UB;
Urologe A; 2015 Jun; 54(6):854-62. PubMed ID: 26024649
[TBL] [Abstract][Full Text] [Related]
38. Generation of antitumor immunity against large colon tumors by repeated runs of electrochemotherapy.
Gunji Y; Uesato M; Miyazaki S; Shimada H; Matsubara H; Nabeya Y; Kouda K; Makino H; Kouzu T; Ochiai T
Hepatogastroenterology; 2005; 52(63):770-4. PubMed ID: 15966202
[TBL] [Abstract][Full Text] [Related]
39. Effects of different applied voltages of irreversible electroporation on prostate cancer in a mouse model.
Kim HB; Zeng CH; Kim Y; Jeong S; Kim SH; Kang JM; Park Y; Won DS; Kim JW; Ryu DS; Lim B; Park JH
Sci Rep; 2022 Dec; 12(1):22336. PubMed ID: 36572706
[TBL] [Abstract][Full Text] [Related]
40. Effectiveness of tumor electrochemotherapy as a function of electric pulse strength and duration.
Satkauskas S; Batiuskaite D; Salomskaite-Davalgiene S; Venslauskas MS
Bioelectrochemistry; 2005 Feb; 65(2):105-11. PubMed ID: 15713560
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
